Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 659

1.

Circulating Endometrial Cells: A New Source of Information on Endometriosis Dynamics.

Pospisilova E, Kiss I, Souckova H, Tomes P, Spicka J, Matkowski R, Jedryka M, Ferrero S, Bobek V, Kolostova K.

J Clin Med. 2019 Nov 11;8(11). pii: E1938. doi: 10.3390/jcm8111938.

PMID:
31717910
2.

Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.

Ferrero S, Scala C, Ciccarelli S, Vellone VG, Barra F.

Gynecol Endocrinol. 2019 Nov 12:1-5. doi: 10.1080/09513590.2019.1689552. [Epub ahead of print]

PMID:
31711348
3.

Proteomic Research of Molecular Defects in Globozoospermia.

Ferrero S, Barra F.

Proteomics Clin Appl. 2019 Oct 22:e1900111. doi: 10.1002/prca.201900111. [Epub ahead of print]

PMID:
31642202
4.

Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes.

Zaccaria GM, Ferrero S, Rosati S, Ghislieri M, Genuardi E, Evangelista A, Sandrone R, Castagneri C, Barbero D, Lo Schirico M, Arcaini L, Molinari AL, Ballerini F, Ferreri A, Omedè P, Zamò A, Balestra G, Boccadoro M, Cortelazzo S, Ladetto M.

JCO Clin Cancer Inform. 2019 Oct;3:1-15. doi: 10.1200/CCI.19.00049.

5.

Methodological concerns on 'Assessment of ovarian reserve after cystectomy versus "one-step" laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial'.

Leone Roberti Maggiore U, Ferrero S.

Hum Reprod. 2019 Oct 2;34(10):2086-2087. doi: 10.1093/humrep/dez140. No abstract available.

PMID:
31585010
6.

MFF REGULATION OF MITOCHONDRIAL CELL DEATH IS A THERAPEUTIC TARGET IN CANCER.

Seo JH, Chae YC, Kossenkov AV, Lee YG, Tang HY, Agarwal E, Gabrilovich DI, Languino LR, Speicher DW, Shastrula PK, Storaci AM, Ferrero S, Gaudioso G, Caroli M, Tosi D, Giroda M, Vaira V, Rebecca VW, Herlyn M, Xiao M, Fingerman D, Martorella A, Skordalakes E, Altieri DC.

Cancer Res. 2019 Oct 3. pii: canres.1982.2019. doi: 10.1158/0008-5472.CAN-19-1982. [Epub ahead of print]

PMID:
31582380
7.

Effects of Active Edible Coating Based on Thyme and Garlic Essential Oils on Lamb Meat Shelf Life After Long-Term Frozen Storage.

Guerrero A, Ferrero S, Barahona M, Boito B, Lisbinski E, Maggi F, Sañudo C.

J Sci Food Agric. 2019 Oct 2. doi: 10.1002/jsfa.10061. [Epub ahead of print]

PMID:
31577841
8.

Unbalanced Pro-Inflammatory and Anti-Inflammatory Cytokines Ratio and Endometriosis: A Contributive Pathogenic Role?

Barra F, Ferrero S.

Iran J Immunol. 2019 Sep;16(3):265-267. doi: 10.22034/IJI.2019.80277. No abstract available.

9.

Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer.

Seo JH, Agarwal E, Chae YC, Lee YG, Garlick DS, Storaci AM, Ferrero S, Gaudioso G, Gianelli U, Vaira V, Altieri DC.

EBioMedicine. 2019 Oct;48:353-363. doi: 10.1016/j.ebiom.2019.09.017. Epub 2019 Sep 18.

10.

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.

Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, Gomez da Silva M, Santoro A, Molinari A, Ferreri A, Grønbæk K, Piccin A, Cortelazzo S, Bertoni F, Ladetto M, Gaidano G.

Haematologica. 2019 Sep 19. pii: haematol.2018.214056. doi: 10.3324/haematol.2018.214056. [Epub ahead of print]

11.

Impact of Endometriomas and Deep Infiltrating Endometriosis on Pregnancy Outcomes and on First and Second Trimester Markers of Impaired Placentation.

Scala C, Leone Roberti Maggiore U, Barra F, Tantari M, Ferrero S.

Medicina (Kaunas). 2019 Aug 30;55(9). pii: E550. doi: 10.3390/medicina55090550.

12.

Relugolix for the treatment of uterine fibroids.

Barra F, Seca M, Della Corte L, Giampaolino P, Ferrero S.

Drugs Today (Barc). 2019 Aug;55(8):503-512. doi: 10.1358/dot.2019.55.8.3020179.

PMID:
31461087
13.

Preoperative Hormonal Treatment Before Laparoscopic Approach for Uterine Fibroids: Do We Need It?

Barra F, Evangelisti G, Ferrero S.

J Invest Surg. 2019 Aug 28:1-3. doi: 10.1080/08941939.2019.1655118. [Epub ahead of print] No abstract available.

PMID:
31456451
14.

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.

Orecchia P, Balza E, Pietra G, Conte R, Bizzarri N, Ferrero S, Mingari MC, Carnemolla B.

Cancers (Basel). 2019 Aug 23;11(9). pii: E1232. doi: 10.3390/cancers11091232.

15.

Separation of low versus high grade Crohn's disease-associated small bowel carcinomas is improved by invasive front prognostic marker analysis.

Arpa G, Grillo F, Giuffrida P, Nesi G, Klersy C, Mescoli C, Lenti MV, Lobascio G, Martino M, Latella G, Malvi D, Macciomei MC, Fociani P, Villanacci V, Rizzo A, Ferrero S, Sessa F, Orlandi A, Monteleone G, Biancone L, Cantoro L, Tonelli F, Ciardi A, Poggioli G, Rizzello F, Ardizzone S, Sampietro G, Solina G, Oreggia B, Papi C, D'Incà R, Vecchi M, Caprioli F, Caronna R, D'Errico A, Fiocca R, Rugge M, Corazza GR, Luinetti O, Paulli M, Solcia E, Di Sabatino A, Vanoli A.

J Crohns Colitis. 2019 Aug 16. pii: jjz140. doi: 10.1093/ecco-jcc/jjz140. [Epub ahead of print]

PMID:
31418007
16.

Cervical intraepithelial neoplasia in women who had vaccination against HPV.

Bogani G, Serati M, Maggiore ULR, Ditto A, Gardella B, Ferrero S, Spinillo A, Ghezzi F, Raspagliesi F.

Int J Gynaecol Obstet. 2019 Nov;147(2):233-237. doi: 10.1002/ijgo.12934. Epub 2019 Aug 8.

PMID:
31361908
17.

Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability.

Fusco N, Lopez G, Corti C, Pesenti C, Colapietro P, Ercoli G, Gaudioso G, Faversani A, Gambini D, Michelotti A, Despini L, Blundo C, Vaira V, Miozzo M, Ferrero S, Bosari S.

JNCI Cancer Spectr. 2018 Dec 13;2(4):pky056. doi: 10.1093/jncics/pky056. eCollection 2018 Oct.

18.

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.

Della Starza I, Cavalli M, De Novi LA, Genuardi E, Mantoan B, Drandi D, Barbero D, Ciabatti E, Grassi S, Gazzola A, Mannu C, Agostinelli C, Piccaluga PP, Bomben R, Degan M, Gattei V, Guarini A, Foà R, Galimberti S, Ladetto M, Ferrero S, Del Giudice I; Fondazione Italiana Linfomi (FIL) MRD Network.

Hematol Oncol. 2019 Oct;37(4):368-374. doi: 10.1002/hon.2652. Epub 2019 Aug 16.

PMID:
31325190
19.

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi.

Merli F, Cavallo F, Salvi F, Tucci A, Musuraca G, Nassi L, Merli M, Tani M, Gini G, Ferrari A, Molinari AL, Liberati AM, Conconi A, Matteucci P, Bari A, Scalone R, Ferrero S, Zanni M, Mammi C, Luminari S.

J Geriatr Oncol. 2019 Jul 8. pii: S1879-4068(18)30482-X. doi: 10.1016/j.jgo.2019.06.020. [Epub ahead of print]

PMID:
31296461
20.

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.

Luminari S, Merli M, Rattotti S, Tarantino V, Marcheselli L, Cavallo F, Varettoni M, Bianchi B, Merli F, Tedeschi A, Cabras G, Re F, Visco C, Torresan Delamain M, Cencini E, Spina M, Ferrero S, Ferrari A, Deodato M, Mannina D, Annibali O, Rago A, Orsucci L, Defrancesco I, Frigeni M, Cesaretti M, Arcaini L.

Blood. 2019 Sep 5;134(10):798-801. doi: 10.1182/blood.2019001088. Epub 2019 Jul 10.

PMID:
31292118
21.

Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension.

Ferro Desideri L, Cutolo CA, Barra F, Ferrero S, Traverso CE.

Drugs Today (Barc). 2019 Jun;55(6):377-384. doi: 10.1358/dot.2019.55.6.2984806. Review.

PMID:
31250842
22.

Synthesis of a Tetracorannulene-perylenediimide That Acts as a Selective Receptor for C60 over C70.

García-Calvo V, Cuevas JV, Barbero H, Ferrero S, Álvarez CM, González JA, Díaz de Greñu B, García-Calvo J, Torroba T.

Org Lett. 2019 Aug 2;21(15):5803-5807. doi: 10.1021/acs.orglett.9b01729. Epub 2019 Jun 26.

PMID:
31241968
23.

Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration.

Ferro Desideri L, Barra F, Ferrero S, Traverso CE, Nicolò M.

Expert Opin Biol Ther. 2019 Aug;19(8):735-751. doi: 10.1080/14712598.2019.1627322. Epub 2019 Jun 13.

PMID:
31180279
24.

Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome.

Dilena R, Mauri E, Aronica E, Bernasconi P, Bana C, Cappelletti C, Carrabba G, Ferrero S, Giorda R, Guez S, Scalia Catenacci S, Triulzi F, Barbieri S, Calderini E, Vezzani A.

Epilepsia Open. 2019 Mar 27;4(2):344-350. doi: 10.1002/epi4.12317. eCollection 2019 Jun.

25.

Atomic force microscopy: a promising aid in diagnosis of uterine smooth muscle neoplasms.

Peñuela LA, Fulcheri E, Vellone VG, Fiocca R, Vigliercio GM, Raiteri R, Ferrero S.

Am J Obstet Gynecol. 2019 Oct;221(4):362-364. doi: 10.1016/j.ajog.2019.05.013. Epub 2019 May 20. No abstract available.

PMID:
31121140
26.

Transforming growth factor β (TGF-β): is there a different role with regard to distinct phenotypes of endometriosis?

Barra F, Ferro Desideri L, Ferrero S.

Immunol Lett. 2019 Jul;211:1-2. doi: 10.1016/j.imlet.2019.05.006. Epub 2019 May 8. No abstract available.

PMID:
31077692
27.

Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.

Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F.

J Gynecol Oncol. 2019 Jul;30(4):e57. doi: 10.3802/jgo.2019.30.e57. Epub 2019 Feb 26.

28.

Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis.

Barra F, Romano A, Grandi G, Facchinetti F, Ferrero S.

Expert Opin Investig Drugs. 2019 Jun;28(6):501-504. doi: 10.1080/13543784.2019.1618269. Epub 2019 May 17. No abstract available.

PMID:
31072144
29.

Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.

Barra F, Scala C, Ferrero S.

Drugs Today (Barc). 2019 Apr;55(4):237-246. doi: 10.1358/dot.2019.55.4.2930713. Review.

PMID:
31050692
30.

Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?

Barra F, Laganà AS, Casarin J, Ghezzi F, Ferro Desideri L, Scala C, Ferrero S.

Int J Fertil Steril. 2019 Jul;13(2):89-92. doi: 10.22074/ijfs.2019.5736. Epub 2019 Apr 27. No abstract available.

31.

Pathophysiology of pain in patients with peritoneal endometriosis.

Ferrero S, Vellone VG, Barra F.

Ann Transl Med. 2019 Mar;7(Suppl 1):S8. doi: 10.21037/atm.2019.01.36. No abstract available.

32.

Estradiol in non-oral hormonal contraception: a "long and winding road".

Grandi G, Barra F, Ferrero S, Facchinetti F.

Expert Rev Endocrinol Metab. 2019 May;14(3):153-155. doi: 10.1080/17446651.2019.1604217. Epub 2019 Apr 27. No abstract available.

PMID:
31030579
33.

Massive Amniotic Fluid Aspiration in a Case of Sudden Neonatal Death With Severe Hypoplasia of the Retrotrapezoid/Parafacial Respiratory Group.

Lavezzi AM, Poloniato A, Rovelli R, Lorioli L, Iasi GA, Pusiol T, Barera G, Ferrero S.

Front Pediatr. 2019 Apr 4;7:116. doi: 10.3389/fped.2019.00116. eCollection 2019.

34.

CT-guided fine-needle aspiration biopsy of solitary pulmonary nodules under 15 mm in diameter: time for an afterthought?

Tosi D, Mendogni P, Carrinola R, Palleschi A, Rosso L, Bonaparte E, Cribiù FM, Ferrero S, Bonitta G, Nosotti M.

J Thorac Dis. 2019 Mar;11(3):724-731. doi: 10.21037/jtd.2019.02.58.

35.

Dual-Tweezer Behavior of an Octapodal Pyrene Porphyrin-Based System as a Host for Fullerenes.

Ferrero S, Barbero H, Miguel D, García-Rodríguez R, Álvarez CM.

J Org Chem. 2019 May 17;84(10):6183-6190. doi: 10.1021/acs.joc.9b00362. Epub 2019 May 2.

PMID:
30993988
36.

Methodological concerns on retinal and choroidal thickness variations measured by optical coherence tomography in patients with epilepsy.

Ferro Desideri L, Barra F, Ferrero S.

Epilepsy Behav. 2019 May;94:312. doi: 10.1016/j.yebeh.2019.02.027. Epub 2019 Apr 11. No abstract available.

PMID:
30982684
37.

Remote sensing application to estimate fish kills by Saprolegniasis in a reservoir.

Bonansea M, Mancini M, Ledesma M, Ferrero S, Rodriguez C, Pinotti L.

Sci Total Environ. 2019 Jun 15;669:930-937. doi: 10.1016/j.scitotenv.2019.02.442. Epub 2019 Feb 28.

PMID:
30970459
38.

3D Printing with the Commercial UV-Curable Standard Blend Resin: Optimized Process Parameters towards the Fabrication of Tiny Functional Parts.

Bertana V, De Pasquale G, Ferrero S, Scaltrito L, Catania F, Nicosia C, Marasso SL, Cocuzza M, Perrucci F.

Polymers (Basel). 2019 Feb 9;11(2). pii: E292. doi: 10.3390/polym11020292.

39.

Diagnostic challenge of intrathoracic tissue misplacements: a thymic choristoma in a fetal lung.

Lopez G, Croci R, Rizzuti T, Ferrero S, Fusco N.

Thorax. 2019 Jun;74(6):624. doi: 10.1136/thoraxjnl-2019-213242. Epub 2019 Apr 2. No abstract available.

PMID:
30940769
40.

Application of failure mode and effect analysis in total laparoscopic hysterectomy in benign conditions.

Lijoi D, Farina M, Puppo A, Novelli A, Ferrero S.

Minerva Ginecol. 2019 Aug;71(4):272-280. doi: 10.23736/S0026-4784.19.04227-8. Epub 2019 Mar 29.

PMID:
30938115
41.

The association between retinal thickness variations and restless leg syndrome (RLS).

Ferro Desideri L, Barra F, Ferrero S.

Sleep Breath. 2019 Sep;23(3):907-908. doi: 10.1007/s11325-019-01817-3. Epub 2019 Mar 18. No abstract available.

PMID:
30887228
42.

Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.

Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R, Mazzilli R, Ferrero S, Palagiano A, Rienzi L.

Front Endocrinol (Lausanne). 2019 Feb 20;10:94. doi: 10.3389/fendo.2019.00094. eCollection 2019. Review.

43.

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines.

D'Agaro T, Zucchetto A, Vit F, Bittolo T, Tissino E, Rossi FM, Degan M, Zaja F, Bulian P, Bo MD, Ferrero S, Ladetto M, Zamò A, Gattei V, Bomben R.

Haematologica. 2019 Sep;104(9):e410-e414. doi: 10.3324/haematol.2018.212811. Epub 2019 Feb 28. No abstract available.

44.

A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.

Barra F, Grandi G, Tantari M, Scala C, Facchinetti F, Ferrero S.

Expert Opin Biol Ther. 2019 Apr;19(4):343-360. doi: 10.1080/14712598.2019.1581761. Epub 2019 Feb 27.

PMID:
30763525
45.

A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes.

Bertolini I, Terrasi A, Martelli C, Gaudioso G, Di Cristofori A, Storaci AM, Formica M, Braidotti P, Todoerti K, Ferrero S, Caroli M, Ottobrini L, Vaccari T, Vaira V.

EBioMedicine. 2019 Mar;41:225-235. doi: 10.1016/j.ebiom.2019.01.051. Epub 2019 Feb 6.

46.

Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas.

Tantari M, Barra F, Di Domenico S, Ferraioli D, Vellone VG, De Cian F, Ferrero S.

Expert Opin Pharmacother. 2019 Apr;20(6):713-723. doi: 10.1080/14656566.2019.1571042. Epub 2019 Feb 6. Review.

PMID:
30724615
47.

Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer.

Ditto A, Leone Roberti Maggiore U, Bogani G, Martinelli F, Chiappa V, Evangelista MT, Liberale V, Ferrero S, Raspagliesi F.

Int J Gynaecol Obstet. 2019 Apr;145(1):28-33. doi: 10.1002/ijgo.12769. Epub 2019 Feb 15.

PMID:
30698271
48.

Inhibitory kappa B alpha expression in endometriosis.

Barra F, Desideri LF, Scala C, Ferrero S.

Turk J Obstet Gynecol. 2018 Dec;15(4):277-278. doi: 10.4274/tjod.37801. Epub 2019 Jan 9. No abstract available.

49.

Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.

Lopez G, Costanza J, Colleoni M, Fontana L, Ferrero S, Miozzo M, Fusco N.

Int J Mol Sci. 2019 Jan 25;20(3). pii: E510. doi: 10.3390/ijms20030510.

50.

In vitro fertilization and autoimmunity: Evidence from an observational study.

Di Rosa R, Ferrero S, Cifani N, Ferri L, Proietta M, Picchianti Diamanti A, Del Porto F.

Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:137-142. doi: 10.1016/j.ejogrb.2018.12.042. Epub 2019 Jan 14.

PMID:
30690189

Supplemental Content

Loading ...
Support Center